The device as well as the production are certified according to the EC guidelines 93/42/EEC Annex II as well as EN ISO 1497:2012, EN ISO 13485:2012 and EN ISO 9001:2008.


papimi is a certified and approved medical device of class IIa.


The American patent was granted on September 17, 1996 (US 5,556,418). The first European patent (EP 0648.140.B1) was granted on January 31, 2001 and the second (EP 04.743.704.1) in August 2003.


Our premium service ensures that your device always performs flawlessly. Our staff will also inform you about our many warranty options.


With the papimi Delta, ion induction therapy (IIT) has arrived in the 21st century. This physical cell therapy sets new standards in medicine. Learn more about the original according to Prof DDr Pappas.

Experts about papimi


  • What is the difference between treating athletes and patients? Which considerations are necessary when taking the integrative approach in performance enhancement? Read about this in the Sportärztezeitung’s 6min article by Andreas König.   About the author: Andreas König is a naturopath, osteopath and physiotherapist. He......

  • SPORTMEDIZINISCHE FORTBILDUNG FÜR ÄRZTE, THERAPEUTEN UND TRAINER SAMSTAG, 02.07.2022 ARCUS SPORTKLINIK PFORZHEIM Programm & Details: Sportärzte Symposium Programm 12. Symposium der sportärztezeitung – sportärztezeitung (

  • Click here to register! After the successful start last year, the next.level.therapie- & trainingszentrum is pleased to invite you to the second Physio and Performance Summit this year. Get inspiration from a day of multifaceted expert lectures, personal discussions and experiences at the individual stations.......

  • We are excited to present our Homepage in Finnish Language (Suomi) and introduce our Finnish partner Innova Medical Oy. See newest Sunday Paper Article about papimi here Don’t miss this upcoming event in Finland: